MarketGrader Israel Index


Five Largest Companies
Symbol Name Grade Market Cap Country
TEVA Teva Pharmaceutical Industries Limited S 50.7 ¤40,436 IL
LUMI.IL Bank Leumi Le-Israel B.M. 75.0 ¤35,570 IL
POLI.IL Bank Hapoalim BM 67.5 ¤32,632 IL
PHOE.IL Phoenix Financial Ltd 56.5 ¤14,387 IL
CHKP Check Point Software Technologies Ltd. 60.7 ¤12,798 IL

Five Smallest Companies
Symbol Name Grade Market Cap Country
KMDA.IL Kamada Ltd 53.5 ¤418 IL
MNIF.IL Menif - Financial Services Ltd. 62.6 ¤454 IL
NAWI.IL Nawi Group Ltd. 68.6 ¤485 IL
ANLT.IL Analyst I.M.S. Investment Management Ser 78.6 ¤589 IL
MPP.IL MORE PROVIDENT FUNDS AND PENSION LTD 67.1 ¤691 IL

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
CHKP Check Point Software Technologies Ltd. 60.7 34 IL
NICE NICE Ltd. Sponsored ADR 62.5 26 IL
POLI.IL Bank Hapoalim BM 67.5 25 IL
LUMI.IL Bank Leumi Le-Israel B.M. 75.0 23 IL
ITRN Ituran Location and Control Ltd. 79.5 15 IL
TEVA Teva Pharmaceutical Industries Limited S 50.7 15 IL
IDIN.IL I.D.I. Insurance Company Ltd. 64.9 11 IL
MMHD.IL Menora Mivtachim Holdings Ltd. 66.0 11 IL
ONE.IL One Software Technologies Ltd. 65.3 11 IL
SMT.IL Summit Real Estate Holdings Ltd 54.6 9 IL
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤6,305
Median Market Cap ¤1,173
Avg. 3 Mo. Dollar Vol. ¤27,821,942
Avg. 3 Mo. Trading Vol. 807,608
Last Rebalance Date 03/23/2026
Companies Replaced 13
Biggest Sector Increase Health Care
Biggest Sector Decrease Technology

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 12.6
Forward P/E Ratio (12 Mo.) 12.9
Price/Book Ratio 3.4
Avg. Revenue Chg. - 3 Yr 69.5%
Avg. Op. Income Chg. - 3 Yr. 100.0%
Avg. EPS Growth - 3 Yr. 30.8%
Avg. EPS Growth - 1 Yr. 24.0%
Avg. Operating Margin 25.3%
Avg. LT Debt to Total Capital 41.5%
Avg. Return on Equity 29.4%
Dividend Yield 3.1%
Index Average Grade
Israel Index 66.0
Country Breakdown
Israel 100.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE